PMC:7074432 / 1780-1972
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 96 | 0-13 | Gene | denotes | Neuraminidase | Gene:4758 |
| 97 | 97-105 | Species | denotes | MERS-CoV | Tax:1335626 |
| 98 | 154-162 | Species | denotes | patients | Tax:9606 |
| 104 | 60-69 | Species | denotes | influenza | Tax:11309 |
| 105 | 172-183 | Chemical | denotes | oseltamivir | MESH:D053139 |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T107 | 14-24 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
| T106 | 97-105 | SP_9 | denotes | MERS-CoV |
| T105 | 172-183 | CHEBI:7798;CHEBI:7798 | denotes | oseltamivir |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T13 | 60-69 | Disease | denotes | influenza | http://purl.obolibrary.org/obo/MONDO_0005812 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T8 | 77-78 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T9 | 140-141 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T10 | 151-153 | http://purl.obolibrary.org/obo/CLO_0001000 | denotes | 35 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T16 | 0-24 | Chemical | denotes | Neuraminidase inhibitors | http://purl.obolibrary.org/obo/CHEBI_52425 |
| T17 | 14-24 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
| T18 | 172-183 | Chemical | denotes | oseltamivir | http://purl.obolibrary.org/obo/CHEBI_7798 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T15 | 0-192 | Sentence | denotes | Neuraminidase inhibitors are indicated in the management of influenza.[9] In a study on possible MERS-CoV cases in Paris from 2013 to 2016, a total of 35 patients received oseltamivir (37.6%). |